SSV Therapeutics, Inc.
Records under this name other than the patents SSV Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 5 of 5 · Back to SSV Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,777,071 | Production of carnitine conjugate intermediates Lapsed on the fee record Ended Aug 17, 2018 · USPTO record | Lapsed on the fee record | Ended Aug 17, 2018 | USPTO record |
| US 7,718,696 | Methods of treating diabetes using carnitine conjugates as dual prodrugs Lapsed on the fee record Ended May 18, 2018 · USPTO record | Lapsed on the fee record | Ended May 18, 2018 | USPTO record |
| US 7,345,190 | Carnitine conjugates as dual prodrugs and uses thereof Lapsed on the fee record Ended Mar 18, 2016 · USPTO record | Lapsed on the fee record | Ended Mar 18, 2016 | USPTO record |
| US 8,049,038 | Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses Lapsed on the fee record Ended Nov 1, 2015 · USPTO record | Lapsed on the fee record | Ended Nov 1, 2015 | USPTO record |
| US 7,977,511 | Carnitine conjugates of adamantanamines and neramexane derivatives as dual prodrugs for various uses Lapsed on the fee record Ended Jul 12, 2015 · USPTO record | Lapsed on the fee record | Ended Jul 12, 2015 | USPTO record |